OpenVSafe by OpenVAERS
Search V-safe

R3Z-26533-17401

3 vaccinations 1 coded response 19 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
288 / NC
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-08
    Registered in v-safe
  3. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-13
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-23
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  13. 2021-01-30
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-20
    Survey response — day 28, dose 2
    MedDRA: Haematoma, Subchorionic haemorrhage, Vaginal haemorrhage — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: New pregnancy complication - large subchorionic hemorrhage and posterior hematoma with significant vaginal bleeding at 141 weeks ega.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-20
    Report sent to call center — day 28, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-02-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-06
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-04
  21. 2021-07-24
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-09-24
    Dose 3 — Pfizer-BioNTech
  23. 2021-10-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-10-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-10-15
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-06Pfizer-BioNTech
22021-01-23Pfizer-BioNTech
32021-09-24Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 4 — day 28, dose 2

2021-02-20

Symptoms: New pregnancy complication - large subchorionic hemorrhage and posterior hematoma with significant vaginal bleeding at 141 weeks ega.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHaematoma ✓ ✓ ✓
SDSubchorionic haemorrhage ✓ ✓ ✓
SDVaginal haemorrhage ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…